BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 4170619)

  • 1. [Differential histochemical aspects of Ewing's sarcoma and metastatic undifferentiated carcinoma].
    Cristallo V
    Arch Ortop; 1966; 79(5):265-70. PubMed ID: 4170619
    [No Abstract]   [Full Text] [Related]  

  • 2. [Recent experiences in 2 cases of Ewing's sarcoma with special reference to histochemical findings with PAS staining and alkaline phosphatases].
    Kitagawa T; Simizu C; Hayashi Y; Kimura O; Kaneda T
    Seikei Geka; 1969 Aug; 20(10):1080-4. PubMed ID: 4187929
    [No Abstract]   [Full Text] [Related]  

  • 3. Cytochemical studies of skeleton neoplasms.
    Petrova AS; Probatova NA
    Folia Histochem Cytochem (Krakow); 1970; 8(2):135-44. PubMed ID: 4920485
    [No Abstract]   [Full Text] [Related]  

  • 4. Nucleophosmin as a candidate prognostic biomarker of Ewing's sarcoma revealed by proteomics.
    Kikuta K; Tochigi N; Shimoda T; Yabe H; Morioka H; Toyama Y; Hosono A; Beppu Y; Kawai A; Hirohashi S; Kondo T
    Clin Cancer Res; 2009 Apr; 15(8):2885-94. PubMed ID: 19351769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of cell death by basic fibroblast growth factor in Ewing's sarcoma.
    Sturla LM; Westwood G; Selby PJ; Lewis IJ; Burchill SA
    Cancer Res; 2000 Nov; 60(21):6160-70. PubMed ID: 11085540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enzymes of round cell tumours in bone and soft tissue: a histochemical survey.
    Jeffree GM
    J Pathol; 1974 Jun; 113(2):101-15. PubMed ID: 4278817
    [No Abstract]   [Full Text] [Related]  

  • 7. Interleukin-12 up-regulates Fas expression in human osteosarcoma and Ewing's sarcoma cells by enhancing its promoter activity.
    Zhou Z; Lafleur EA; Koshkina NV; Worth LL; Lester MS; Kleinerman ES
    Mol Cancer Res; 2005 Dec; 3(12):685-91. PubMed ID: 16380506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cytologic and cytochemical characteristics of Ewing's tumor and reticulosarcoma of the bone].
    Esiutina OS
    Lab Delo; 1972; 4():218-21. PubMed ID: 4119842
    [No Abstract]   [Full Text] [Related]  

  • 9. Overexpression of p53 protein in primary Ewing's sarcoma of bone: relationship to tumour stage, response and prognosis.
    Abudu A; Mangham DC; Reynolds GM; Pynsent PB; Tillman RM; Carter SR; Grimer RJ
    Br J Cancer; 1999 Mar; 79(7-8):1185-9. PubMed ID: 10098757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. beta-Adrenergic receptors in pediatric tumors: uncoupled beta 1-adrenergic receptor in Ewing's sarcoma.
    Whitsett JA; Burdsall J; Workman L; Hollinger B; Neely J
    J Natl Cancer Inst; 1983 Oct; 71(4):779-86. PubMed ID: 6312152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Nonspecific phosphatases and their role in the morpho- and histogenesis of skeletal tumors].
    KraevskiÄ­ NA; Petrova AS; Probatova NA
    Arkh Patol; 1968; 30(8):6-17. PubMed ID: 4302209
    [No Abstract]   [Full Text] [Related]  

  • 12. Expression of functional CD40 on human osteosarcoma and Ewing's sarcoma cells.
    Lollini PL; Landuzzi L; Frabetti F; Rossi I; Nicoletti G; Scotlandi K; Serra M; Baldini N; De Giovanni C; Nanni P
    Clin Cancer Res; 1998 Aug; 4(8):1843-9. PubMed ID: 9717810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absence of HER2/neu gene expression in osteosarcoma and skeletal Ewing's sarcoma.
    Thomas DG; Giordano TJ; Sanders D; Biermann JS; Baker L
    Clin Cancer Res; 2002 Mar; 8(3):788-93. PubMed ID: 11895910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Procollagens as markers for the cell of origin of human bone tumors.
    Stern R; Wilczek J; Thorpe WP; Rosenberg SA; Cannon G
    Cancer Res; 1980 Feb; 40(2):325-8. PubMed ID: 6927962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PKC-theta expression in Ewing sarcoma/primitive neuroectodermal tumour and malignant peripheral nerve sheath tumour.
    Kang GH; Kim KM; Park CK; Kang DY
    Histopathology; 2009 Sep; 55(3):368-9. PubMed ID: 19723158
    [No Abstract]   [Full Text] [Related]  

  • 16. XAGE-1, a new gene that is frequently expressed in Ewing's sarcoma.
    Liu XF; Helman LJ; Yeung C; Bera TK; Lee B; Pastan I
    Cancer Res; 2000 Sep; 60(17):4752-5. PubMed ID: 10987281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RNA-based nanoparticle treatment shows promise in Ewing's sarcoma model.
    Hede K
    J Natl Cancer Inst; 2005 May; 97(9):627. PubMed ID: 15870430
    [No Abstract]   [Full Text] [Related]  

  • 18. Overexpression of papillomavirus binding factor in Ewing's sarcoma family of tumors conferring poor prognosis.
    Yabe H; Tsukahara T; Kawaguchi S; Wada T; Sato N; Morioka H; Yabe H
    Oncol Rep; 2008 Jan; 19(1):129-34. PubMed ID: 18097586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ewing's sarcoma: transplantation in nude rat.
    Buffe D; Rimbaut C; Mazabraud A; Thiery JP; Zucker JM; Salomon JC; Lascaux V; Rudant C
    Biomed Pharmacother; 1983; 37(5):233-6. PubMed ID: 6661510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intramyofiber skeletal muscle invasion in Ewing's sarcoma of bone: clinicopathologic observations from the intergroup Ewing's sarcoma study.
    Stratton B; Askin FB; Kissane JM
    Am J Pediatr Hematol Oncol; 1982; 4(2):231-5. PubMed ID: 7114406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.